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Abstract 
Aqueous extract of Psidium guajava L. budding leaves (PE) has been 
shown to possess anti-prostate cancer activity in a cell line model. We 
examined whether its bioactivity could be conserved either in the presence 
or the absence of synthetic androgen R1881. In both cases, PE was shown 
to inhibit LNCaP cell proliferation and down-regulate expressions of 
androgen receptor (AR) and prostate specific antigen (PSA). The 
cytotoxicity of PE was shown by enhanced LDH release in LNCaP cells. 
The flow cytometry analysis revealed cell cycle arrests at G(0)/G(1) phase 
with huge amount of apoptotic LNCaP cells after treatment with PE for 48 
h in a dose-responsive manner, which was also confirmed by TUNEL assay. 
From the results of decreased Bcl-2/Bax ratio, inactivation of 
phosphor-Akt, activation of phosphor-p38, phospho-Erk1/phospho-Erk2, 
the molecular action mechanism of PE to induce apoptosis in LNCaP cells 
was elucidated. Compatible with the in vitro study findings, treatment with 
PE (1.5 mg/mouse/day) significantly diminished both the PSA serum 
levels and tumor size in a xenograft mouse tumor model. Conclusively, PE 
is a promising anti-androgen-sensative prostate cancer agent. 
 
 
 
 
